Plain-English translation of NCT05753306 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new surgical approach for patients with stomach cancer that has spread to the tissue lining the abdomen. The treatment combines robot-assisted surgery (which uses smaller incisions than traditional surgery) with heated chemotherapy—specifically docetaxel and —that is delivered directly into the abdominal cavity during the operation. Researchers believe this combination may help patients recover faster and experience fewer complications than traditional open surgery.
Stomach cancer that spreads to the abdominal lining is very serious and has poor survival rates. Traditional open surgery to treat this condition requires large incisions and carries a high risk of complications and longer hospital stays. This trial is exploring whether using robotic surgery with smaller incisions, combined with heated chemotherapy, can improve outcomes and reduce recovery time.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will undergo blood and stool collection before and after your surgery. You will then have robot-assisted surgery to remove your stomach and affected tissues, during which heated chemotherapy will be delivered directly into your abdomen. Throughout the trial, you will have imaging scans (CT, MRI, or PET/CT) to monitor how well the treatment is working. You will be followed closely by the research team to track your recovery and watch for any side effects.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
United States